𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic hepatitis in liver allografts

✍ Scribed by Stefan G. Hubscher; Mrcpath; Raouf E. Nakhleh; Dale C. Snover


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
176 KB
Volume
12
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cholestatic hepatitis C in liver allogra
✍ Taga, Scott A. ;Washington, M. Kay ;Terrault, Norah ;Wright, Teresa L. ;Somberg, πŸ“‚ Article πŸ“… 1998 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 171 KB

Some liver allograft recipients with hepatitis C virus (HCV) infection develop hyperbilirubinemia, which might be the result of a cholestatic variant of hepatitis C. We evaluated all liver biopsy samples from 6 liver transplant recipients who had polymerase chain reaction-positive HCV infection and

Evolution of hepatitis C virus in liver
✍ Anthony J. Demetris πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 102 KB

1. Hepatitis C virus (HCV) RNA+ liver allograft recipients invariably reinfect the liver allograft within hours after transplantation, and the majority (>70%) develop chronic hepatitis. The rate at which these patients experience progression to cirrhosis and the overall percentage are significantly

Plasma cell hepatitis in liver allograft
✍ Anthony J. Demetris; Mylene Sebagh πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 134 KB

In this issue, Fiel et al. 1 use the phrase "plasma cell hepatitis (de novo autoimmune hepatitis)" to describe what they eventually conclude to be a variant of acute rejection. This study was likely prompted by curiosity about the significance of plasma cell-rich infiltrates in liver allograft biops

CD40L (CD154) expression in human liver
✍ Gaweco, Anderson S. ;Wiesner, Russell H. ;Yong, Sherri ;Krom, Ruud ;Porayko, Mic πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 226 KB

The CD40-CD40L (CD154) interaction plays a pivotal role in the effector mechanisms of allograft rejection. Blockade of the CD40/CD40L costimulatory pathway prevents the development of chronic allograft rejection in several animal transplant models. The relevance of in situ CD40 and CD40L expression